Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Oculus Announces China Marketing Plan for Microcyn

publication date: May 19, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Oculus Innovative Sciences of Petaluma, CA has firmed up a plan for commercializing its Microcyn® products in China, following SFDA approval two months ago. Oculus’ China distribution partner, China Bao Tai, will distribute samples of Microcyn to key opinion leaders, asking them to test the clinical effect of the product by conducting post-approval trials. The data will be used to help secure reimbursement from insurance institutions. More details...

Stock Symbol: (NSDQ: OCLS)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...